TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+28.75%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$278M
AUM Growth
+$278M
(-2.7%)
Cap. Flow
-$67.7M
Cap. Flow
% of AUM
-24.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$39.8M |
| 2 |
Editas Medicine
EDIT
|
$27.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Voyager Therapeutics
VYGR
$186M
| $176M | 63.52% |
9,391,176
| – | – |
|
|
JNCE
2
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $68.1M | 24.53% |
3,048,780
| – | – |
|
|
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $33.2M | 11.95% |
680,272
-816,326
| -55% | -$39.8M |
|
|
4
Editas Medicine
EDIT
$231M
| – | – |
-906,176
| Closed | -$27.8M |
|